Analyst Coverage

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Analyst Coverage

KemPharm, Inc. is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding KemPharm, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of KemPharm, Inc. or its management. KemPharm, Inc. does not by its reference below imply its endorsement of or concurrence with such information, conclusions or recommendations. Furthermore, KemPharm, Inc. may not and is not obligated to update publicly any such coverage information as changes may occur in the future.
Firm Analysts
Canaccord Genuity Inc.
Dewey Steadman, CFA
Cowen & Company, LLC
Ken Cacciatore
Janney Montgomery Scott LLC
Ken Trbovich, CFA
Oppenheimer & Co., Inc.
Christopher Liu
RBC Capital Markets, LLC
Randall Stanicky, CFA
Roth Capital Partners
Scott Henry, CFA